Latest news
Loading news…
Twelve Bio
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Copenhagen, Hovedstaden, Denmark Founded 2019 1-10 employees For Profit
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence.
Twelve Bio was acquired by Ensoma in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
0
2 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 6
- Patents granted
- 0
- Trademarks
- 2
Company Info
- Founded
- 2019
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 4
- HQ
- Copenhagen, Hovedstaden, Denmark
- Region
- European Union (EU), Nordic Countries, Scandinavia
- Exit date
- Jan 5, 2023
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -0.3
Key People at Twelve Bio
Co-Founder
Executive Chair(wo)man
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Twelve Bio
Loading news…
FAQs about Twelve Bio
People who checked this page also checked these
Browse the full Acquirezy directory.